OKUR

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

OnKure Therapeutics, Inc.

NASDAQ | OKUR

3.14

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 13, 2025)

$41.73M

Market Cap

-

P/E Ratio

-4.68

EPS

$16.91

52 Week High

$1.70

52 Week Low

HEALTHCARE

Sector

OKUR Chart

Recent Chart
Price Action

OKUR Technicals

Tags:

OKUR Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$662K
Total Revenue $0
Cost Of Revenue $662K
Costof Goods And Services Sold $662K
Operating Income -$54M
Selling General And Administrative $11M
Research And Development $44M
Operating Expenses $54M
Investment Income Net -
Net Interest Income $1.7M
Interest Income $2M
Interest Expense $300K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $662K
Income Before Tax -$53M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$53M
Comprehensive Income Net Of Tax -
Ebit -$52M
Ebitda -$52M
Net Income -$53M

Revenue & Profitability

Earnings Performance

OKUR Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $115M
Total Current Assets $113M
Cash And Cash Equivalents At Carrying Value $111M
Cash And Short Term Investments $111M
Inventory -
Current Net Receivables -
Total Non Current Assets $1.9M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $2.2M
Other Non Current Assets -
Total Liabilities $11M
Total Current Liabilities $11M
Current Accounts Payable $3M
Deferred Revenue -
Current Debt -
Short Term Debt $536K
Total Non Current Liabilities $549K
Capital Lease Obligations $1.1M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $1.1M
Other Current Liabilities $7M
Other Non Current Liabilities -
Total Shareholder Equity $104M
Treasury Stock -
Retained Earnings -$155M
Common Stock $1K
Common Stock Shares Outstanding $13M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$51M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $662K
Capital Expenditures $52K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $16M
Cashflow From Financing $116M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$53M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$662K
Total Revenue $0
Cost Of Revenue $662K
Costof Goods And Services Sold $662K
Operating Income -$54M
Selling General And Administrative $11M
Research And Development $44M
Operating Expenses $54M
Investment Income Net -
Net Interest Income $1.7M
Interest Income $2M
Interest Expense $300K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $662K
Income Before Tax -$53M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$53M
Comprehensive Income Net Of Tax -
Ebit -$52M
Ebitda -$52M
Net Income -$53M

OKUR News

OKUR Profile

OnKure Therapeutics, Inc. Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

OnKure Therapeutics, Inc. is an innovative biopharmaceutical firm dedicated to revolutionizing cancer treatment through the development of precision oncology therapies. Located in Boulder, Colorado, the company utilizes cutting-edge drug discovery platforms to target unmet needs in cancer care, showcasing a strong commitment to personalized medicine. With a diverse pipeline of targeted therapeutic candidates, OnKure is poised to make significant strides in enhancing patient outcomes and reshaping the landscape of oncology.

NVVE
+204.60%
$0.47
LPTX
+368.57%
$2.05
TNMG
+37.18%
$0.41
CMND
+11.56%
$0.34
ONDS
+19.05%
$6.56
RUBI
+16.35%
$0.23
NVDA
-3.58%
$186.86
VHAI
-25.00%
$0.00
SOND
+8.82%
$0.18
PFE
-0.30%
$25.79
TSLA
-6.64%
$401.99
SOFI
-11.85%
$28.39
ASST
-10.85%
$1.15
PLUG
-8.79%
$2.49
BITF
-17.98%
$2.60
WTO
-33.55%
$0.02
YDKG
-18.03%
$0.02
INTC
-5.22%
$35.91
ACHR
-7.97%
$7.96
DRCT
+44.06%
$0.28
BYND
-9.41%
$1.01
DNN
-3.86%
$2.49
F
-1.26%
$13.28
SGBX
+32.21%
$3.16
ETHD
+14.22%
$5.14
MGRX
-32.38%
$1.19
AXDX
-61.36%
$0.03
RGTI
-10.95%
$25.20
PLTR
-6.53%
$172.14
AMD
-4.22%
$247.96
NIO
-3.25%
$6.24
SNAP
-5.61%
$8.58
RIVN
-6.44%
$16.39
CSCO
+4.62%
$77.38
NOK
-3.41%
$6.78
CIFR
-14.09%
$14.93
TLRY
-8.13%
$1.13
MARA
-11.31%
$12.78
GRAB
-4.31%
$5.54
CRCL
-4.58%
$82.34
CAN
-10.18%
$0.97
ADAP
-15.14%
$0.05
CHR
+3.90%
$0.04
T
+0.38%
$25.75
QBTS
-11.40%
$23.39
IREN
-12.65%
$48.65
AAPL
-0.19%
$272.95
BBD
-0.54%
$3.66
DIS
-7.74%
$107.61
WULF
-7.59%
$11.68
SOUN
-7.70%
$12.22
BTBT
-11.26%
$2.52
CRWV
-8.29%
$78.34
HPE
-2.34%
$22.93
NBIS
-6.07%
$88.63
RIG
-2.90%
$4.01
AMZN
-2.71%
$237.58
BMNR
-9.85%
$36.57
RMBL
+60.50%
$3.21
BTE
+3.63%
$3.14
UGRO
-16.39%
$0.25
LNW
-3.71%
$86.22
AAL
-2.89%
$13.07
ADD
-25.47%
$0.05
IONZ
+20.63%
$5.67
BAC
-2.29%
$52.87
SMCI
-7.43%
$35.09
IONQ
-10.47%
$45.40
GPUS
-10.20%
$0.30
SRM
+53.27%
$10.30
CLSK
-10.12%
$11.98
HIMS
-7.61%
$36.05
EPWK
-38.09%
$0.04
QS
-7.30%
$13.57
BURU
-8.60%
$0.25
MU
-3.24%
$236.95
JD
-1.72%
$30.71
APLD
-12.68%
$23.06
KVUE
+0.59%
$16.77
VZ
+0.75%
$41.11
WBD
-0.22%
$22.14
HOOD
-9.51%
$120.33
ORCL
-4.15%
$217.57
GOOGL
-2.83%
$278.57
BTG
-1.91%
$4.10
AMCR
+2.02%
$8.58
WLGS
-5.57%
$0.04
RIOT
-10.21%
$13.88
BE
-18.28%
$103.55
QUBT
-9.96%
$10.03
MTSR
-0.35%
$70.50
SMR
-10.82%
$23.15
PLTZ
+13.00%
$7.04
DKNG
-5.77%
$29.69
VSA
-20.34%
$0.23
JOBY
-9.26%
$14.79
RKLB
-9.44%
$45.25
NGD
-4.08%
$7.27
ABEV
-0.39%
$2.52
HBAN
-1.50%
$15.71
NVVE
+204.60%
$0.47
LPTX
+368.57%
$2.05
TNMG
+37.18%
$0.41
CMND
+11.56%
$0.34
ONDS
+19.05%
$6.56
RUBI
+16.35%
$0.23
NVDA
-3.58%
$186.86
VHAI
-25.00%
$0.00
SOND
+8.82%
$0.18
PFE
-0.30%
$25.79
TSLA
-6.64%
$401.99
SOFI
-11.85%
$28.39
ASST
-10.85%
$1.15
PLUG
-8.79%
$2.49
BITF
-17.98%
$2.60
WTO
-33.55%
$0.02
YDKG
-18.03%
$0.02
INTC
-5.22%
$35.91
ACHR
-7.97%
$7.96
DRCT
+44.06%
$0.28
BYND
-9.41%
$1.01
DNN
-3.86%
$2.49
F
-1.26%
$13.28
SGBX
+32.21%
$3.16
ETHD
+14.22%
$5.14
MGRX
-32.38%
$1.19
AXDX
-61.36%
$0.03
RGTI
-10.95%
$25.20
PLTR
-6.53%
$172.14
AMD
-4.22%
$247.96
NIO
-3.25%
$6.24
SNAP
-5.61%
$8.58
RIVN
-6.44%
$16.39
CSCO
+4.62%
$77.38
NOK
-3.41%
$6.78
CIFR
-14.09%
$14.93
TLRY
-8.13%
$1.13
MARA
-11.31%
$12.78
GRAB
-4.31%
$5.54
CRCL
-4.58%
$82.34
CAN
-10.18%
$0.97
ADAP
-15.14%
$0.05
CHR
+3.90%
$0.04
T
+0.38%
$25.75
QBTS
-11.40%
$23.39
IREN
-12.65%
$48.65
AAPL
-0.19%
$272.95
BBD
-0.54%
$3.66
DIS
-7.74%
$107.61
WULF
-7.59%
$11.68
SOUN
-7.70%
$12.22
BTBT
-11.26%
$2.52
CRWV
-8.29%
$78.34
HPE
-2.34%
$22.93
NBIS
-6.07%
$88.63
RIG
-2.90%
$4.01
AMZN
-2.71%
$237.58
BMNR
-9.85%
$36.57
RMBL
+60.50%
$3.21
BTE
+3.63%
$3.14
UGRO
-16.39%
$0.25
LNW
-3.71%
$86.22
AAL
-2.89%
$13.07
ADD
-25.47%
$0.05
IONZ
+20.63%
$5.67
BAC
-2.29%
$52.87
SMCI
-7.43%
$35.09
IONQ
-10.47%
$45.40
GPUS
-10.20%
$0.30
SRM
+53.27%
$10.30
CLSK
-10.12%
$11.98
HIMS
-7.61%
$36.05
EPWK
-38.09%
$0.04
QS
-7.30%
$13.57
BURU
-8.60%
$0.25
MU
-3.24%
$236.95
JD
-1.72%
$30.71
APLD
-12.68%
$23.06
KVUE
+0.59%
$16.77
VZ
+0.75%
$41.11
WBD
-0.22%
$22.14
HOOD
-9.51%
$120.33
ORCL
-4.15%
$217.57
GOOGL
-2.83%
$278.57
BTG
-1.91%
$4.10
AMCR
+2.02%
$8.58
WLGS
-5.57%
$0.04
RIOT
-10.21%
$13.88
BE
-18.28%
$103.55
QUBT
-9.96%
$10.03
MTSR
-0.35%
$70.50
SMR
-10.82%
$23.15
PLTZ
+13.00%
$7.04
DKNG
-5.77%
$29.69
VSA
-20.34%
$0.23
JOBY
-9.26%
$14.79
RKLB
-9.44%
$45.25
NGD
-4.08%
$7.27
ABEV
-0.39%
$2.52
HBAN
-1.50%
$15.71
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.